Xuhui Liu
14 Papers
Xuhui Liu is an academic researcher. The author has contributed to research in topics: Medicine & Tuberculosis. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
COVID-19 with Different Severities: A Multicenter Study of Clinical Features.
Yun Feng,Yun Ling,Tao Bai,Yusang Xie,Jie Huang,Jian Li,Weining Xiong,Dexiang Yang,Rong Chen,Fang-Ying Lu,Yunfei Lu,Xuhui Liu,Yuqing Chen,Xin Li,Yong Li,Hanssa Dwarka Summah,Huihuang Lin,Jiayang Yan,Min Zhou,Hongzhou Lu,Jieming Qu +20 more
TL;DR: Multiple organ dysfunction and impaired immune function were the typical characteristics of patients with severe or critical illness and there was a significant difference in the use of angiotensin-converting enzyme inhibitors/angiotens in II receptor blockers among patients with different severities of disease.
861
The effect of BCG vaccination and risk factors for latent tuberculosis infection among college freshmen in China.
Wei Huang,Zhixiong Fang,Si Luo,Shan Lin,Lei Xu,Bo Yan,Yang Yang,Xuhui Liu,Lu Xia,Xiao-yong Fan,Shuihua Lu +10 more
TL;DR: In this paper , the Bacillus Calmette-Guérin (BCG) vaccination was used to protect first-year college students against Mycobacterium tuberculosis (MTB) infection by the recombinant fusion protein ESAT6-CFP10 skin test (ECST) or the tuberculin skin test(TST).
15
An Updated Review on MSMD Research Globally and A Literature Review on the Molecular Findings, Clinical Manifestations, and Treatment Approaches in China
TL;DR: Wang et al. as discussed by the authors conducted a systematic review of PubMed (MEDLINE), the Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, EMBASE, CNKI, and Wanfang to summarize the clinical characteristics, diagnosis, treatment, and prognosis of MSMD in China.
Factors associated with loss to follow-up before and after treatment initiation among patients with tuberculosis: A 5-year observation in China
You-Jin Jiang,Jingfang Chen,Meng Ying,Linlin Liu,Min Li,Shu-Ming Lu,Zhihuan Li,Peize Zhang,Qi Xie,Xuhui Liu,Hongzhou Lu +10 more
TL;DR: Wang et al. as discussed by the authors found that loss to follow-up is frequent in the management of patients with TB and can be predicted using patients’ treatment history, clinical characteristics, and socioeconomic factors.
9
High Accuracy of Recombinant Fusion Protein ESAT6-CFP10 Skin Test for the Detection of Tuberculosis Infection: A Phase III, Multi-centered, Double-blind, Hospital-based, Randomized Controlled Trial.
Lu Xia,Miao Xu,Tao Li,Heng Yang,Weihua Wang,Qi Wu,Youlun Li,Xiaohong Chen,Qinfang Ou,Naihui Chu,Hongqiu Pan,Qunyi Deng,Xiaodong Mei,Douglas B. Lowrie,Xuhui Liu,Guozhi Wang,Shu-Ming Lu +16 more
TL;DR: In this paper , a multi-center, double-blind, randomized controlled trial was conducted from December 17, 2015, to March 2, 2018 to verify the diagnostic utility of recombinant fusion protein ESAT6-CPF10 (EC), a novel skin test reagent to detect Mycobacterium tuberculosis infection.
6